{name}
{subtitle}
A Clinical Study Evaluating The Benefit of Adding Rucaparib to Enzalutamide for Men With Metastatic Prostate Cancer That Has Become Resistant To Testosterone-Deprivation Therapy
city
~30 mi. (Fresno, California, +233 more cities)
facility
Kaiser Permanente-Fresno
drug
degarelix, +4 more drugs
drug type
hormone therapy, +1 more type
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~30 mi. (Fresno, California, +825 more cities)
facility
Kaiser Permanente-Fresno, +1 more facility
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Study of Nivolumab in Combination With Ipilimumab or Standard of Care Chemotherapy Compared to the Standard of Care Chemotherapy Alone in Treatment of Participants With Untreated Inoperable or Metastatic Urothelial Cancer
city
~30 mi. (Fresno, California, +172 more cities)
facility
VA of Central California Health Care System
drug
cisplatin, +3 more drugs
drug type
chemotherapy, +1 more type
A Study Evaluating the Efficacy and Safety of Adjuvant Atezolizumab or Placebo and Trastuzumab Emtansine for Participants With HER2-Positive Breast Cancer at High Risk of Recurrence Following Preoperative Therapy
city
~30 mi. (Fresno, California, +260 more cities)
facility
California Cancer Associate for Research & Excellence
biomarker
ERBB2 Amplification, +1 more biomarker
drug type
immunotherapy, +1 more type